Competitive Landscape of Autoimmune Disease Diagnostics Market Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
Buy NowAutoimmune Disease Diagnostics Market Companies Analysis
The Autoimmune Disease Diagnostics industry is forecast to witness tremendous growth, anticipated to reach an astonishing US$ 10.63 billion by 2033 from US$ 5.70 billion in 2024. Such phenomenal growth is forecast to be achieved through a compound annual growth rate (CAGR) of 7.17% between 2025 and 2033. Various fundamental drivers are driving this growth, such as a growing need for accurate and trustworthy diagnostic tools. Moreover, there is an increased emphasis on patient outcomes and wellbeing.
Diagnostic technologies are being revolutionized to facilitate more precise diagnoses, while strategic alliances and cooperative agreements among industry leaders are creating avenues for advancements and improvements. Autoimmune disease testing is the term used to denote the variety of tests and examinations employed to diagnose autoimmune disease, in which the body's immune system attacks its own tissues mistakenly. Such diseases affect all kinds of organs and systems, resulting in a broad spectrum of symptoms, so diagnosing them is usually difficult. The investigation often starts with a good patient history and physical check-up, followed by laboratory investigations aimed at detecting certain autoantibodies or inflammatory markers.
Routine tests include tests for antinuclear antibodies (ANA), rheumatoid factor (RF), and organ-specific autoantibodies. The test results allow health professionals to assess for the conditions lupus, rheumatoid arthritis, or multiple sclerosis. Precise testing is important because it helps with treatment and follow-up on disease activity. In addition, new diagnostic methods, including genetic analysis and imaging, advance our knowledge of autoimmunity and its expression. By properly diagnosing the disease, patients are able to obtain timely medical treatment, enhancing their quality of life as well as potentially contributing to more effective long-term outcomes.
Major Players of Autoimmune Disease Diagnostics
Abbott Laboratories
Year Founded: 1888
Headquarter: United States of America
Website: www.abbott.com
Revenue: $42.0B in 2023
Abbott Laboratories (Abbott) is a medical device and health care company that produces, creates, makes, and sells products. Gastroenterology, women's health, cardiovascular and metabolic, pain and central nervous system, respiratory drugs and vaccines, biosimilars, core laboratory and transfusion medicine systems, point-of-care systems, rapid diagnostics lateral flow testing, informatics and automation solutions, nutritional products, rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products, and neuromodulation products are some of its main offerings. The company distributes its products to customers in North America, Latin America, the Middle East, Europe, Asia-Pacific, and Africa through distributors, wholesalers, government agencies, hospitals, pharmacies, and independent retailers. Abbott's US headquarters are in Abbott Park, Illinois.
Bio-Rad Laboratories
Founding: 1952
Headquarters: United States of America
Website: www.bio-rad.com
Revenue: $2.6B in 2023
Instruments, software, consumables, and reagents are designed, manufactured, and sold by Bio-Rad Laboratories Inc. (Bio-Rad) to be used in life science research and clinical diagnostics. Some of its offerings include digital PCR, blood typing and antibody detection systems, antibodies, autoimmune diagnostic kits, and cell isolation and analysis equipment. Some of the areas where the company's products find application include immunology, gene expression analysis, cell research, bioprocess analytics, and mutation detection. It offers its services to hospitals, public health and commercial laboratories, universities and research institutions, diagnostic manufacturers, and food, chemical, pharmaceutical, and biotechnology businesses. Bio-Rad distributes its products through distributors, agencies, brokers, resellers, and direct sales. Besides other locations, the company has its operations in the US, Germany, France, China, and Singapore. The US city of Hercules, California, hosts the headquarters of Bio-Rad.
Roche Diagnostics
Establishment: 1896
Headquarters: Switzerland
Website: www.roche.ch/en/sites/rotkreuz/about-roche-diagnostics-international
Physician offices, labs, and clinics are able to purchase diagnostic system solutions from Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd. The company develops, produces, and supports software and hardware systems for bioanalytical research and in-vitro diagnostics. It also supplies molecular diagnostic reagents, test systems, workflow solutions, and analysis systems for diagnostics. Point-of-care testing instruments and blood glucose meters are among its core products. Hospitals, diagnostic commercial laboratories, medical practitioners, researchers, and pharmacists form some of the firm's customers through its products and services. Roche Diagnostics' headquarters are in Rotkreuz, Switzerland.
Siemens Healthineers
Founding: 1847
Headquarters: Germany
Website: www.siemens-healthineers.com
Revenue: $24.2B in 2023
A subsidiary of Siemens AG, Siemens Healthineers AG (Siemens Healthineers) is a manufacturer of medical technology. Imaging solutions, in vitro diagnostic solutions, and sophisticated treatments are some of the diagnostic and therapeutic products that the company designs, develops, manufactures, and markets. Molecular imaging systems, X-rays, ultrasound, computed tomography, magnetic resonance imaging, testing, point-of-care (POC) testing, transportable C-arms, hybrid operating rooms, and angiography are some of the company's flagship products. It also offers digital and enterprise solutions. Clinical laboratories, clinics, hospitals, hospital networks, physicians, public health institutions, universities, commercial and state-operated health insurances, pharmaceutical companies, and clinical research centers are just some of the many clients the company works for. The company has facilities across Asia-Pacific, Africa, the Middle East, the Americas, and Europe. The headquarters of Siemens Healthineers is in Forchheim, Bayern, Germany.
Bio Merieux SA
Founded: 1963
Headquarter: France
Website: www.biomerieux.fr
Revenue: $1.3B in 2023
A subsidiary of Institut Merieux SA, bioMerieux SA (bioMerieux) develops, manufactures, and markets in vitro diagnostic items to be used in private clinics and medical laboratories. Besides identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products, the company offers diagnostic solutions, such as systems, reagents, and software, for the identification of infectious diseases, cardiovascular diseases, and cancers. It offers industrial microbiological control solutions to the food industry, pharmaceuticals and cosmetics industries, veterinary diagnostic laboratories, blood banks, as well as immunoassays, microbiology products, molecular biology tests, and other solutions to clinical uses. bioMerieux also provides bacterial flora counting systems, which disclose the food product's quality. The company markets its products both directly and through a worldwide network of distributors. The head office of bioMerieux is in Marcy l'Etoile, France.
Myriad Genetics, Inc.
Founding: 1991
Head Office: United States of America
Website: myriad.com
Revenue: $837.6M in 2023
Myriad Genetics Inc. (Myriad) is a focused molecular diagnostic company that provides clinical and pharmaceutical products and services for significant diseases as well as discovering and marketing molecular diagnostic tests and personalized medication. Molecular diagnostic products that analyze genes, genetic expressions, and related proteins to establish an individual's risk of developing disease in adulthood, as well as disease diagnosis-related products and products used to establish a patient's probability of responding to a particular medication, are some of the firm's products. Myriad distributes its products via distributor contracts in Canada, the Middle East, Asia, and Australia, as well as sales representatives in Europe and Canada. Spain, France, Switzerland, the United Kingdom, Canada, Italy, Germany, Japan, Australia, and the Netherlands are some of the nations where the company operates. The headquarters of the company is in the US city of Salt Lake City, Utah.
Quest Diagnostics Incorporated Autoimmune Disease Diagnostics Product Launches
In July 2025, Quest Diagnostics will begin offering the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic test from Fujirebio this summer. It is the first FDA-cleared blood test to assist in the identification of amyloid pathology associated with Alzheimer's disease. It helps in the evaluation of adults aged 50 and above who present signs of cognitive decline.
Thermo Fisher Scientific Inc. Autoimmune Disease Diagnostics Product Launches
Dec. 2023 – Thermo Fisher Scientific signed a sole distributor agreement with Aesku.Group to distribute and support the FDA-Cleared IFA products, automated equipment, and software of Aesku.Group in the United States. This agreement strengthens Thermo Fisher's portfolio of automated diagnostic systems by offering customers an extended line of autoimmune diagnostics and instrumentation, such as Aesku's IFA testing and Helios HTC systems, in addition to the EliA™ and Phadia™ lines.
SWOT Analysis of the EUROIMMUN
Strength: Broad Autoimmune Testing Portfolio - EUROIMMUN differentiates itself within the autoimmune disease diagnostics industry because of its broad and clinically established testing portfolio. The company features more than 150 specialty tests and broad panels that help in the prompt diagnosis of major autoimmune diseases, such as rheumatoid arthritis, lupus, myositis, interstitial lung disease, and systemic sclerosis. These tests are optimized to aid screening, diagnosis, treatment decisions, and continuous monitoring of over 80 autoimmune disorders. EUROIMMUN's testing solutions are clinically supported and in accordance with guidelines from authoritative health organizations, providing solid and accurate results. Through offering a complete set of autoimmune testing solutions, EUROIMMUN empowers physicians to make informed decisions, resulting in improved patient outcomes in treating autoimmune diseases.
SWOT Analysis of the Inova Diagnostics
Strength: Comprehensive Autoimmune Testing Portfolio - Inova Diagnostics leads the autoimmune disease diagnostics industry through its comprehensive and clinically established testing portfolio. The firm has more than 150 specialty tests and comprehensive panels that support the swift diagnosis of important autoimmune diseases, such as rheumatoid arthritis, lupus, myositis, interstitial lung disease, and systemic sclerosis. These tests enable screening, diagnosis, treatment, and continued monitoring for over 80 autoimmune conditions. Inova's test solutions are evidence-based and supported by guidelines from top health organizations, providing accurate and consistent results. By providing a wide panel of autoimmune testing, Inova Diagnostics allows healthcare professionals to make informed choices, which results in improved patient outcomes in the management of autoimmune diseases.
Current Development in Grifols Company
July 2025 – Grifols, the largest manufacturer of plasma-derived pharmaceuticals, revealed an investment of EUR 160 million in a new plant in Lliçà de Vall (Barcelona). This new facility will double its plasma fractionation capacity in Europe and multiply its capability to treat more than 300,000 patients in the continent, reaffirming its commitment to Catalonia, Spain, and Europe.
Current Development in LabCorp Company
August 1, 2025, Diagnostic leader Labcorp has released Test Finder, a generative AI solution developed in partnership with Amazon Web Services (AWS). Test Finder is intended to simplify selecting lab tests for healthcare professionals by allowing them to pose questions or describe conditions in plain terms. The tool responds with customized test recommendations. Test Finder was developed on Amazon Bedrock, a service that facilitates the building of generative AI apps and agents backed by large language models. Furthermore, the tool also provides providers with a comprehensive list of recommended tests with descriptions based on what they provided.
Trinity Biotech Sustainability Goal
Trinity Biotech sustainability objectives revolve around creating long-term value via environmental stewardship, responsible business practices, and sustainable diagnostic innovation. The corporation is committed to minimizing its environmental impact by streamlining production processes, reducing waste, and enhancing energy efficiency in its plants. One of the foundations of its sustainability vision is the incorporation of environmentally friendly design in new products, including reusable or low-waste diagnostic equipment, that meet international healthcare sustainability standards. Responsible supply and ethical procurement are also prioritized by Trinity Biotech, with full compliance with environmental and social regulations. In addition, it is dedicated to the creation of diagnostic technologies that improve world health with reduced material consumption and carbon emissions. Through ongoing development, community outreach, and reporting transparency, Trinity Biotech strives to be a positive force in environmental stewardship and public health, solidifying its role as a responsible global leader in the medical diagnostics market.
Becton Dickinson Sustainability Goal
Becton Dickinson & Company (BD) has set ambitious sustainability targets through its "Together We Advance" environment, social, and governance (ESG) strategy. Its vision for sustainability is centered on human health improvement and reducing its environmental impact. BD also plans to cut its Scope 1 and 2 greenhouse gas emissions by 46% in 2030 and reach carbon neutrality in its direct operations by 2040. BD also pledges to enhance resource efficiency by reducing energy consumption, water usage, and waste generation through sustainable manufacturing and packaging approaches. BD incorporates sustainability into product design to increase circularity and minimize the use of virgin plastics. In addition, the company prioritizes ethical sourcing, community involvement, and workforce diversity, ensuring a positive social contribution. Through its alignment of its sustainability efforts with worldwide frameworks like the UN Sustainable Development Goals, BD seeks to spur long-term strength, innovation, and environmental stewardship in its global operations.
Global Autoimmune Disease Diagnostics Market
- Historical Trends
- Forecast Analysis
Market Share Analysis – Global Autoimmune Disease Diagnostics Industry
Archer Daniels Midland Company
Overview
- Company History and Mission
- Business Model and Operations
- Workforce
Key Persons
- Executive Leadership
- Operational Management
- Division Leaders
- Board Composition
Recent Development & Strategies
- Mergers & Acquisitions
- Partnerships
- Investments
Sustainability Analysis
- Renewable Energy Adoption
- Energy-Efficient Infrastructure
- Use of Sustainable Packaging Materials
- Water Usage and Conservation Strategies
- Waste Management and Circular Economy Initiatives
Product Analysis
- Product Profile
- Quality Standards
- Product Pipeline
- Product Benchmarking
Strategic Assessment: SWOT Analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
Revenue Analysis
The above information will be available for all the following companies:
- Abbott Laboratories
- Bio-Rad Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Bio Merieux SA
- Myriad Genetics, Inc.
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
- EUROIMMUN
- Inova Diagnostics (Werfen)
- Grifols
- LabCorp
- Revvity
- Trinity Biotech
- BD (Becton Dickinson)